Skip to main navigation Skip to search Skip to main content

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab—Authors' reply

Research output: Contribution to journalComment/Letter to the editorAcademic

19 Downloads (Pure)

Cite this